Benefit of Cardiopoietic Mesenchymal Stem Cell Therapy on Left Ventricular Remodelling: Results From the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) Study

European Journal of Heart Failure - United States
doi 10.1002/ejhf.898

Related search